CD
Clarissa Desjardins (Director) filed 1 Form 4 report in the past 24 months (1 purchase, 0 sales), most often in Insmed Incorporated (INSM). Across 1 priced purchase filing, the average 21-session return was +46.8% from execution and +59.9% from disclosure (delay-adjusted; derived). The largest single filing was $127K of INSM (1,895 sh × $66.87, as filed), executed May 20 2025. Data as of Nov 8 2026.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
+46.8%
avg across 1 priced filings
Delay-adjustediThe same average, entered at disclosure dates
+59.9%
same 1 filings, from disclosure
Filings, ttm
1
1 buys · 0 sells
Median delay
2d
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$127K
shares × price, as filed
Last traded
May 20 2025
Filed May 22 2025
Median ADV $401.1M across their filed names
Open performance→Volume by month
Buys $127K
Sells $0
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
1 filing
Sector per market data · by filing · past 24 months
Most traded names
INSMRecent filings
INSMPURCHASE
Insmed Incorporated
View filing →
$127K1,895 sh × $66.87
Exec May 20 2025
Filed May 22 2025 · 5:30 PM ET